LC3B antibody | knockout validation | Abcam ab192890

This is a knockout-validated antibody summary, based on the publication "Autophagy deficiency exacerbates acute lung injury induced by copper oxide nanoparticles", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

LC3B antibody | knockout validation | Abcam ab192890 figure 1
Figure 1. Wild type and lc3b-/- mice were intratracheally instilled of vehicle or 5 mg/kg CuONPs, respectively, then the lung tissues and BALFs of indicated groups were collected 3 days after treatment. The protein expression levels of LC3B-I/II in the mice lung tissues were determined by western blot analysis. β-actin served as internal control. From [1].
Antibody information

Rabbit monoclonal IgG

Company: Abcam

Antibody: LC3B

Catalog number: ab192890

Summary: Rabbit monoclonal antibody against a synthetic peptide of LC3B. Reacts with mouse, rat and human. Suitable for western blot, immunoprecipitation, immunocytochemistry/immunofluorescence, and immunohistochemistry (paraffin).

Validation Method

Western blot

Sample

WT and lc3b-/- mice lung tissues and bronchoalveolar lavage fluids (BALFs).

Blocking agent

5% nonfat milk in TBST.

Primary incubation

1:3,000 dilution overnight at 4 °C.

Secondary incubation

HRP-conjugated secondary antibodies.

Detection

ChemiDoc Touch Imaging system (1708370, Bio-Rad).

References
  1. Xiao J, Tu B, Zhou X, Jiang X, Xu G, Zhang J, et al. Autophagy deficiency exacerbates acute lung injury induced by copper oxide nanoparticles. J Nanobiotechnology. 2021;19:162 pubmed publisher